Maya Boustani

Dr. Maya Boustani


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Journal of Affective Disorders
Verified
Journal Article
Closed access
LRLeslie R. Rith-Najarian
Leslie R. Rith-Najarian
MBMaya Boustani
Maya Boustani
BCBruce F. Chorpita
Bruce F. Chorpita

1 April 2010 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
GDGayle A. Dakof
Gayle A. Dakof
JCJeri B. Cohen
Jeri B. Cohen
CHCraig E. Henderson
Craig E. Henderson
EDEliette Duarte
Eliette Duarte
MBMaya Boustani
Maya Boustani
SHSam Hawes
Sam Hawes

7 February 2014 in Administration and Policy in Mental Health and Mental Health Services Research
Verified
Journal Article
Closed access
PDF file
MBMaya Boustani
Maya Boustani
SFStacy L. Frazier
Stacy L. Frazier
KBKimberly D. Becker
Kimberly D. Becker
MBMichele Bechor
Michele Bechor
SDSonya M. Dinizulu
Sonya M. Dinizulu
DPDave S. Pasalich
Dave S. Pasalich

1 April 2015 in Journal of Family Psychology
Verified
Journal Article
Open access
GDGayle A. Dakof
Gayle A. Dakof
CHCraig E. Henderson
Craig E. Henderson
CRCynthia L. Rowe
Cynthia L. Rowe
MBMaya Boustani
Maya Boustani
PGPaul E. Greenbaum
Paul E. Greenbaum
HLHoward A. Liddle
Howard A. Liddle
The objective of this article is to examine the effectiveness of 2 theoretically different treatments delivered in juvenile drug court--family therapy represented by multidimensional family therapy (MDFT) and group-based treatment represented by adolescent group therapy (AGT)--on offending and substance use. Intent-to-treat sample included 112 youth enrolled in juvenile drug court (primarily male [88%], and Hispanic [59%] or African American [35%]), average age 16.1 years, randomly assigned to either family therapy (n = 55) or group therapy (n = 57). Participants were assessed at baseline and 6, 12, 18 and 24 months following baseline. During the drug court phase, youth in both treatments showed significant reduction in delinquency (average d = .51), externalizing symptoms (average d = 2.32), rearrests (average d = 1.22), and substance use (average d = 4.42). During the 24-month follow-up, family therapy evidenced greater maintenance of treatment gains than group-based treatment for externalizing symptoms (d = 0.39), commission of serious crimes (d = .38), and felony arrests (d = .96). There was no significant difference between the treatments with respect to substance use or misdemeanor arrests. The results suggest that family therapy enhances juvenile drug court outcomes beyond what can be achieved with a nonfamily based treatment, especially with respect to what is arguably the primary objective of juvenile drug courts: reducing criminal behavior and rearrests. More research is needed on the effectiveness of juvenile drug courts generally and on whether treatment type and family involvement influence outcomes. Clinical Trials.gov, Identified NCT01668303.

26 November 2014 in Administration and Policy in Mental Health and Mental Health Services Research
Verified
Journal Article
Closed access
PDF file
SFStacy L. Frazier
Stacy L. Frazier
SDSonya Mathies Dinizulu
Sonya Mathies Dinizulu
DRDana Rusch
Dana Rusch
MBMaya Boustani
Maya Boustani
TMTara G. Mehta
Tara G. Mehta
KRKristin Reitz
Kristin Reitz

29 September 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MBMaya Boustani
Maya Boustani
SLStephanie Lunn
Stephanie Lunn
UVUbbo Visser
Ubbo Visser
CLChristine Lisetti
Christine Lisetti
Background: Digital health agents — embodied conversational agents designed specifically for health interventions — provide a promising alternative or supplement to behavioral health services by reducing barriers to access to care. Objective: Our goals were to (1) develop an expressive, speech-enabled digital health agent operating in a 3-dimensional virtual environment to deliver a brief behavioral health intervention over the internet to reduce alcohol use and to (2) understand its acceptability, feasibility, and utility with its end users. Methods: We developed an expressive, speech-enabled digital health agent with facial expressions and body gestures operating in a 3-dimensional virtual office and able to deliver a brief behavioral health intervention over the internet to reduce alcohol use. We then asked 51 alcohol users to report on the digital health agent acceptability, feasibility, and utility. Results: The developed digital health agent uses speech recognition and a model of empathetic verbal and nonverbal behaviors to engage the user, and its performance enabled it to successfully deliver a brief behavioral health intervention over the internet to reduce alcohol use. Descriptive statistics indicated that participants had overwhelmingly positive experiences with the digital health agent, including engagement with the technology, acceptance, perceived utility, and intent to use the technology. Illustrative qualitative quotes provided further insight about the potential reach and impact of digital health agents in behavioral health care. Conclusions: Web-delivered interventions delivered by expressive, speech-enabled digital health agents may provide an exciting complement or alternative to traditional one-on-one treatment. They may be especially helpful for hard-to-reach communities with behavioral workforce shortages.